Detalhe da pesquisa
1.
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Cell
; 183(2): 347-362.e24, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064988
2.
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1.
Cell Rep Med
; 1(8): 100141, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294862
3.
Endocardially Derived Macrophages Are Essential for Valvular Remodeling.
Dev Cell
; 48(5): 617-630.e3, 2019 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799229
4.
In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1+ BCP-ALL.
Blood Adv
; 2(11): 1229-1242, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29853524